These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6515424)

  • 1. Molecular markers of hemostatic activation: future perspectives.
    Fareed J; Baker WH; Walenga JM; Messmore HL
    Semin Thromb Hemost; 1984 Oct; 10(4):329-32. PubMed ID: 6515424
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrocoagulography using integral indices in assessing hemostatic disorders in children].
    Baranov AA
    Anesteziol Reanimatol; 1988; (6):59-61. PubMed ID: 3245625
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical implications of molecular markers in hemostasis and thrombosis.
    Bick RL
    Semin Thromb Hemost; 1984 Oct; 10(4):290-3. PubMed ID: 6515423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New tests for the study of hemostasis and their interpretation].
    Vergoz D
    Rev Prat; 1973 Nov; 23(53):61-2, 65-6. PubMed ID: 4802274
    [No Abstract]   [Full Text] [Related]  

  • 6. [Etiologic evaluation of deep venous thrombosis: hemostasis tests to perform].
    Sie P
    Ann Biol Clin (Paris); 1985; 43(6):817-9. PubMed ID: 3841708
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemostasis: Part I. Screening tests to evaluate abnormal hemostasis.
    Longberry J
    Am J Med Technol; 1982 Feb; 48(2):99-105. PubMed ID: 7064992
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver disease, coagulation testing, and hemostasis.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):265-82. PubMed ID: 19665678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives in diagnosis of hemostasis disorders.
    Dati F; Becker U; Hissung A; Keller F
    Ann Biol Clin (Paris); 1988; 46(3):201-10. PubMed ID: 3408028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the hemostatic platelet and plasma systems in patients with pulmonary tuberculosis].
    Kaminskaia GO; Serebrianaia BA; Martynova EV
    Probl Tuberk Bolezn Legk; 2007; (4):38-41. PubMed ID: 17657966
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality in hemostasis and thrombosis--part I.
    Favaloro EJ; Plebani M; Lippi G
    Semin Thromb Hemost; 2012 Sep; 38(6):549-52. PubMed ID: 22941783
    [No Abstract]   [Full Text] [Related]  

  • 13. New approaches for measuring coagulation.
    Barrowcliffe TW; Cattaneo M; Podda GM; Bucciarelli P; Lussana F; Lecchi A; Toh CH; Hemker HC; Béguin S; Ingerslev J; Sørensen B
    Haemophilia; 2006 Jul; 12 Suppl 3():76-81. PubMed ID: 16684000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving techniques for monitoring clotting in plasma and whole blood samples.
    Carr ME; Martin EJ
    Clin Lab; 2004; 50(9-10):539-49. PubMed ID: 15481629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory evaluation of hemostatic disorders.
    Hassouna HI
    Hematol Oncol Clin North Am; 1993 Dec; 7(6):1161-249. PubMed ID: 8294314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
    Angelos MG; Hamilton GC
    Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal and maternal hemostasis: value of molecular markers in the assessment of hemostatic status.
    Suarez CR; Menendez CE; Walenga JM; Fareed J
    Semin Thromb Hemost; 1984 Oct; 10(4):280-4. PubMed ID: 6515421
    [No Abstract]   [Full Text] [Related]  

  • 18. Discrepancies between clotting and chromogenic assays in congenital coagulation disorders: the hemostatic coin has only one face, chromogenic substrates many.
    Girolami A; Vettore S
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):484-5. PubMed ID: 19675419
    [No Abstract]   [Full Text] [Related]  

  • 19. [The determination of hemostatic defects in aeronautical personnel].
    Blundo G; Paolucci G; Rota P
    Riv Med Aeronaut Spaz; 1975; 38(4):427-32. PubMed ID: 9092063
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemostasis and coagulation].
    Bataille R; Roux JL
    Actual Odontostomatol (Paris); 1965 Sep; 71():261-88. PubMed ID: 5847392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.